Scientists' worst fears about Trump's cuts to research funding haven't come to pass, thanks to several legal challenges and ...
Pharming Group (NASDAQ:PHAR) outlined its 2026 financial guidance and provided updates on its commercial portfolio and late-stage pipeline during its 2026 Investor Day, emphasizing continued revenue ...
Amgen (NASDAQ:AMGN) executives highlighted broad-based growth in 2025 and laid out expectations for continued momentum in ...
The agency’s program will be open to pharmaceutical facilities that align with “national priorities.” Elsewhere, a ...
Quarterly Activities Report for the period ending 31 2025 Pivotal quarter for Vulcan Energy after securing a comprehensive ...
Vulcan Energy Resources delivered the financing package to support a positive Financial Investment Decision for the Phase One Lionheart Project in the quarter ending 31 2025. Phase One Lionheart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results